PF-06463922 for Crizotinib Pretreated ROS1 Positive Non-small-cell Lung Cancer

Clinical trial NCT03439215 · UNKNOWN

Trial details

NCT number: NCT03439215
Sponsor: Fondazione Ricerca Traslazionale
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2017-06-13
Primary completion: 2022-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.